These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3232037)

  • 1. Proresid in the long-term treatment of rheumatoid arthritis.
    Lysholm J; Weitoft T
    Scand J Rheumatol; 1988; 17(6):465-8. PubMed ID: 3232037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proresid therapy in rheumatoid arthritis. A comparison with injectable gold using life-table analysis.
    Bendix G; Bjelle A
    Scand J Rheumatol; 1993; 22(2):77-82. PubMed ID: 8480142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rheumatoid patients with Proresid.
    Lysholm J; Weitoft T
    Scand J Rheumatol; 1990; 19(2):170. PubMed ID: 2336553
    [No Abstract]   [Full Text] [Related]  

  • 4. Proresid--a valuable and well-tolerated drug?
    Larsen A
    Scand J Rheumatol; 1989; 18(4):245. PubMed ID: 2799309
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushingoid picture with Proresid.
    Könyves AL; Almqvist EG; Holmberg DH
    Br J Rheumatol; 1994 Dec; 33(12):1198. PubMed ID: 8000762
    [No Abstract]   [Full Text] [Related]  

  • 6. Side effects of Proresid in the treatment of chronic arthritis.
    Weitoft T; Lysholm J
    Scand J Rheumatol; 1988; 17(1):63-6. PubMed ID: 3368755
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer morbidity in rheumatoid arthritis patients treated with Proresid or parenteral gold.
    Bendix G; Bjelle A; Holmberg E
    Scand J Rheumatol; 1995; 24(2):79-84. PubMed ID: 7747148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheumatoid arthritis treated with proresid (author's transl)].
    Hunziker M; Sarkany G; Hunziker H
    Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1399-401. PubMed ID: 928305
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of primary chronic polyarthritis using the immunosuppressive, cytostatically active podophyllin derivative, Proresid].
    Szántó L; Görgényi F; Benczur M; Reviczky A; Lörinez G; Gömör B
    Med Welt; 1973 Apr; 24(14):539-41. PubMed ID: 4704283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive treatment of progressive chronic polyarthritis. Experiences with an antimitotic drug from the podophyllin series (Proresid)].
    Chlud K; Prohaska E; Zeitlhofer J; Pfaller C; Friza B
    Munch Med Wochenschr; 1968 Jan; 110(2):88-97. PubMed ID: 5695131
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience in the treatment of rheumatoid polyarthritis with Imuran and Proresid in outpatient units].
    Suteanu S; Dănilă E; Ionescu-Pirvu V; Rindaşu G; Ciocan A; Steflea M; Alexandru G; Ciobanu V
    Med Interna (Bucur); 1973 Dec; 25(12):1491-7. PubMed ID: 4792568
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
    Wawrzyńska-Pagowska J; Graff-Wróblewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Scislowska M
    Z Rheumaforsch; 1973; 32(1):32-9. PubMed ID: 4693416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemolytic transfusion incident caused by a Kidd-antibody, anti-Jka].
    Sedlmayer A
    Wien Klin Wochenschr; 1983 Nov; 95(21):773-5. PubMed ID: 6673369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of rheumatoid arthritis with the immunosuppresive agent, prorezid].
    Todorov B
    Vutr Boles; 1977; 16(3):47-52. PubMed ID: 331687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the synovial fluid following intra-articular injections of Proresid].
    Vojtísek O; Freund U; Greiling H
    Fysiatr Revmatol Vestn; 1969 Dec; 47(6):275-80. PubMed ID: 4188551
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
    Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
    J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proresid in the treatment of lung cancer].
    Gurbiel T; Juszczyński M
    Pol Tyg Lek; 1971 Sep; 26(38):1461-3. PubMed ID: 5112757
    [No Abstract]   [Full Text] [Related]  

  • 19. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts.
    Edwards A; Atma-Ram A; Thin RN
    Genitourin Med; 1988 Aug; 64(4):263-5. PubMed ID: 3169757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of anti-inflammatory treatment of rheumatoid arthritis by means of thermography].
    Pakuła A; Kruszewski S
    Reumatologia; 1978; 16(2):245-9. PubMed ID: 694259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.